Mithra Pharmaceuticals (CHIX:MITRAB) Accounts Payable & Accrued Expense : €44.71 Mil (As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Mithra Pharmaceuticals Accounts Payable & Accrued Expense?

Mithra Pharmaceuticals's quarterly accounts payable & accrued expense increased from Jun. 2022 (€27.58 Mil) to Dec. 2022 (€52.06 Mil) but then declined from Dec. 2022 (€52.06 Mil) to Jun. 2023 (€44.71 Mil).

Mithra Pharmaceuticals's annual accounts payable & accrued expense declined from Dec. 2020 (€48.09 Mil) to Dec. 2021 (€34.28 Mil) but then increased from Dec. 2021 (€34.28 Mil) to Dec. 2022 (€52.06 Mil).

Mithra Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Mithra Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mithra Pharmaceuticals Accounts Payable & Accrued Expense Chart

Mithra Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

13.89

21.06

48.09

34.28

52.06

Mithra Pharmaceuticals Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															19.31	34.28	27.58	52.06	44.71

Mithra Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Mithra Pharmaceuticals (CHIX:MITRAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mithra Pharmaceuticals SA (CHIX:MITRAb) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

0R91:UK 1TM:Germany MITRA:Belgium

Address

Rue Saint-Georges 5, Liege, BEL, 4000

Website

https://www.mithra.com

Mithra Pharmaceuticals SA develops products for women's health with a particular focus on fertility, contraception, and menopause. It operates in three segments: Product Sales, Out-licensing, and Other. The company also develops and markets complex therapeutic solutions and offers partners a complete spectrum of research, development, and specialist manufacturing at its Mithra CDMO. Its geographical segments are Belgium, Europe and Outside Europe.

Mithra Pharmaceuticals (CHIX:MITRAB) Headlines

No Headlines